Follow
Dr. István Hajdu
Dr. István Hajdu
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
Combined nano-membrane technology for removal of lead ions
I Hajdu, M Bodnár, Z Csikós, S Wei, L Daróczi, B Kovács, Z Győri, ...
Journal of Membrane Science 409, 44-53, 2012
1162012
Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery
Z Keresztessy, M Bodnár, E Ber, I Hajdu, M Zhang, JF Hartmann, T Minko, ...
Colloid and Polymer Science 287, 759-765, 2009
752009
Nanoparticles prepared by self-assembly of chitosan and poly-γ-glutamic acid
I Hajdu, M Bodnár, G Filipcsei, JF Hartmann, L Daróczi, M Zrínyi, ...
Colloid and Polymer Science 286, 343-350, 2008
742008
99mTc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities
A Polyák, I Hajdu, M Bodnár, G Trencsényi, Z Pöstényi, V Haász, G Jánoki, ...
International journal of pharmaceutics 449 (1-2), 10-17, 2013
492013
Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68Ga-and 44Sc-labeled DOTA-NAPamide in melanoma imaging
G Nagy, N Dénes, A Kis, JP Szabó, E Berényi, I Garai, P Bai, I Hajdu, ...
European Journal of Pharmaceutical Sciences 106, 336-344, 2017
462017
Synthesis of 68Ga-labeled biopolymer-based nanoparticle imaging agents for positron-emission tomography
Z Körhegyi, D Rózsa, I Hajdu, M Bodnár, I Kertesz, K Kerekes, S Kun, ...
Anticancer research 39 (5), 2415-2427, 2019
242019
Folate receptor targeted self-assembled chitosan-based nanoparticles for SPECT/CT imaging: Demonstrating a preclinical proof of concept
A Polyák, I Hajdu, M Bodnár, G Dabasi, RP Jóba, J Borbély, L Balogh
International Journal of Pharmaceutics 474 (1-2), 91-94, 2014
232014
Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD)
I Hajdu, J Angyal, D Szikra, I Kertész, M Malanga, É Fenyvesi, L Szente, ...
European Journal of Pharmaceutical Sciences 128, 202-208, 2019
202019
Tumor-specific localization of self-assembled nanoparticle PET/MR modalities
I Hajdu, G Trencsenyi, M Bodnar, M Emri, G Banfalvi, J Sikula, T Marian, ...
Anticancer research 34 (1), 49-59, 2014
182014
Gemini surfactant-based systems for drug and gene delivery
A Makhlouf, I Hajdu, I Badea
Organic Materials as Smart Nanocarriers for Drug Delivery, 561-600, 2018
152018
Cancer cell diagnosis by targeting delivery of nanodevices
J Borbely, M Bodnar, JF Hartmann, I Hajdu, J Kollar, G Vamosi
US Patent 7,976,825, 2011
152011
Biopolymer-based nanosystem for ferric ion removal from water
M Bodnár, I Hajdu, E Rőthi, N Harmati, Z Csikós, JF Hartmann, C Balogh, ...
Separation and Purification Technology 112, 26-33, 2013
142013
Cancer cell targeting and imaging with biopolymer-based nanodevices
I Hajdu, M Bodnár, G Trencsényi, T Márián, G Vámosi, J Kollár, J Borbély
International journal of pharmaceutics 441 (1-2), 234-241, 2013
142013
111In-Labeled Glycoprotein Nonmetastatic b (GPNMB) Targeted Gemini Surfactant-Based Nanoparticles against Melanoma: In Vitro Characterization and in Vivo …
A Makhlouf, I Hajdu, SV Hartimath, E Alizadeh, K Wharton, KM Wasan, ...
Molecular Pharmaceutics 16 (2), 542-551, 2019
112019
In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography
G Trencsényi, A Kis, JP Szabó, Á Ráti, K Csige, É Fenyvesi, L Szente, ...
International Journal of Pharmaceutics 576, 118954, 2020
102020
A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
I Hajdu, A Makhlouf, VR Solomon, D Michel, M Al-Dulaymi, KM Wasan, ...
International journal of nanomedicine, 7801-7818, 2018
92018
Polymeric Nanoparticles by ion-ion interactions
J Berbely, M Bodnar, I Hajdu, JF Hartmann, Z Keresztessy, L Nagy, ...
US Patent App. 11/881,831, 2008
92008
In vivo preclinical assessment of novel 68Ga-labelled peptides for imaging of tumor associated angiogenesis using positron emission tomography imaging
N Dénes, A Kis, JP Szabó, I Jószai, I Hajdu, V Arató, KN Enyedi, G Mező, ...
Applied Radiation and Isotopes 174, 109778, 2021
82021
In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice
K Csige, JP Szabó, I Kálmán-Szabó, NS Dénes, D Szikra, Z Képes, ...
International Journal of Pharmaceutics 625, 122132, 2022
72022
In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron …
JP Szabó, K Csige, I Kálmán-Szabó, V Arató, G Opposits, I Jószai, ...
International Journal of Pharmaceutics 630, 122462, 2023
62023
The system can't perform the operation now. Try again later.
Articles 1–20